REACTINE

This brand name is authorized in Brazil, Canada, Germany, France, Netherlands

Active ingredients

The drug REACTINE contains one active pharmaceutical ingredient (API):

1 Cetirizine UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE

Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors. Read about Cetirizine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
REACTINE Tablet, Capsule, Syrup	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AE07	Cetirizine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514519120034517
Country: CA	Health Products and Food Branch	Identifier(s): 01900978, 02223546, 02223554, 02238337, 02246162, 02358352, 02368064, 02467577, 02486954
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02152240
Country: FR	Base de données publique des médicaments	Identifier(s): 64939766
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 26298